Dr. Crow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11801 South Fwy
Burleson, TX 76028Phone+1 817-293-4304
Education & Training
Duke University HospitalFellowship, Hematopathology, 2009 - 2010- Duke University HospitalResidency, Pathology-Anatomic and Clinical, 2005 - 2009
Rutgers New Jersey Medical SchoolClass of 2005
Certifications & Licensure
NC State Medical License 2005 - 2025
TX State Medical License 2015 - 2025- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 42 citationsClinical Significance of DNA Variants in Chronic Myeloid Neoplasms: A Report of the Association for Molecular PathologyRebecca F. McClure, Mark D. Ewalt, Jennifer Crow, Robyn L. Temple-Smolkin, Mrudula Pullambhatla
The Journal of Molecular Diagnostics. 2018-11-01 - 7 citationsBlast phase in chronic myelogenous leukemia is skewed toward unusual blast types in patients treated with tyrosine kinase inhibitors: a comparative study of 67 cases.Yang Shi, Andrew J. Rand, Jennifer H. Crow, Joseph O. Moore, Anand S. Lagoo
American Journal of Clinical Pathology. 2015-01-01 - 12 citationsFoxP3 and indoleamine 2,3-dioxygenase immunoreactivity in sentinel nodes from melanoma patients.Marisa A. Ryan, Jennifer H. Crow, Russel Kahmke, Samuel R. Fisher, Zuowei Su
American Journal of Otolaryngology. 2014-11-01
Press Mentions
- Senior Living: Companies Pan for Marketing Gold in Coronavirus VaccinesMarch 15th, 2021
Friday, Feb 19 2021February 19th, 2021- First Edition: Feb. 19, 2021February 19th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
